Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study
/
DateApr 10 2024
SAN RAMON, Calif., April 10, 2024 (GLOBE NEWSWIRE) — Raydiant Oximetry, Inc., a clinical-stage medical device company that develops medical technologies to improve outcomes for... Read More →